BioCurate Pty Ltd
Tifelle Reisinger currently serves as the Associate Director of Medicinal Chemistry Discovery and Stakeholder Management at BioCurate Pty Ltd, where responsibilities include overseeing the MRFF-Biomedical Translation Bridge Program and managing relationships with key industry partners. With extensive experience in drug discovery, Tifelle has held various roles at Domainex, including Australian Business Strategist and Head of Business Development for Asia Pacific, and has also contributed as a Senior Synthetic Organic Chemist at Peakdale Molecular. Educational qualifications include a Ph.D. in Organic Chemistry from the Institut de Chimie des Substances Naturelles and completion of leadership programs through the Australian Institute of Company Directors and WILD. Tifelle’s expertise encompasses medicinal chemistry, project management, and stakeholder engagement within the pharmaceutical and biotechnology sectors.
This person is not in the org chart
This person is not in any teams
BioCurate Pty Ltd
In order to realise the full potential of Australia’s innovation opportunities, new approaches are required to take discoveries through the process of translation and early commercialisation - the so-called ‘valley of death’. It is precisely this ‘valley’ that a newly launched $80 million enterprise, BioCurate Pty Ltd, aims to traverse in the field of biomedical drug development. BioCurate has been formed as a joint venture between two leading Australian Universities, the University of Melbourne and Monash University. As an independent venture catalyst, BioCurate will target this critical phase of development and provide the commercial focus, expertise and funding, necessary to boost successful translation and commercialisation.